STOCKHOLDERS' EQUITY (DEFICIT) - EQUITY-CLASSIFIED AWARDS (Details) - USD ($)		12 Months Ended
	Feb. 09, 2021	Sep. 30, 2021
Shares
Granted (in shares)	665,000
Equity-classified share options
Shares
Outstanding at the beginning of the period (in shares)		0
Granted (in shares)		665,000
Exercised (in shares)		0
Expired/Forfeited (in shares)		(50,000)
Outstanding at the end of the period (in shares)		615,000
Exercisable at the end of period (in shares)		0
Weighted-Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)		$ 0
Granted (in dollars per share)		3.36
Exercised (in dollars per share)		0
Expired/Forfeited (in dollars per share)		3.33
Outstanding at the end of the period (in dollars per share)		3.36
Exercisable at the end of period (in dollars per share)		$ 0
Weighted-Average Remaining Contractual Term
Options outstanding, weighted average remaining contractual life		8 years 10 months 24 days
Aggregate Intrinsic Value
Options outstanding, aggregate intrinsic value		$ 0
Options exercisable, aggregate intrinsic value		$ 0